NPY and neoplasm: The development of multifunctional NPY-conjugates for selective nuclear delivery of radio lanthanides (targeted radionuclide therapy) is a promising strategy to deliver therapeutically active cargos (e.g., radiometals) into tumor cells overexpressing peptide receptors (e.g., Y1R) [255].